Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-12-18
1999-08-03
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514319, 514327, 514330, 514331, 514354, 514357, 514423, 514438, 514451, 514565, 514588, 514595, 514618, 514625, 514628, 514825, 514885, 514900, 514903, 546192, 546195, 546225, 546227, 546229, 546233, 546235, 546238, 546239, 546242, 546245, 548531, 548537, 548566, 548572, 549 66, 549 71, 549426, 549427, 562431, 562452, 562503, 562504, 562507, 562555, 562556, 564 42, 564 56, 564 57, 564209, 564224, A01N 4340, A01N 4336, A01N 3710, C07C41500, C07C23300, C07D21108, C07D20700, C07D33332
Patent
active
059325950
ABSTRACT:
The present invention relates to compounds of Formula I: ##STR1## that are matrix metalloprotease inhibitors, pharmaceutical compositions containing them, methods for their use and methods of preparing these compounds.
REFERENCES:
patent: 4268516 (1981-05-01), Lombardino et al.
patent: 4394520 (1983-07-01), Kalopissis
patent: 5183900 (1993-02-01), Galardy et al.
patent: 5189178 (1993-02-01), Galardy et al.
patent: 5268391 (1993-12-01), Hanson et al.
patent: 5475013 (1995-12-01), Talley et al.
Cas Registry Handbook: American Chemical Society, 1965-1971; RN: 331-89-5; 331-90-8; 331-93-1; 405-23-2; 780-95-0; 5463-52-5; 5464-62-0; 5445-04-5; 5445-05-6; 5460-58-2; 6803-08-3; 6534-37-8; 21056-72-4.
Clayton, et al., Tetrahedron, vol. 49:4, 1993, Oxford GB, pp. 939-946, "Direct Aromatic tert-Butylation during the Synthesis of Thiochroman-4-ones".
Chemical Abstracts, vol. 125:13, Sep. 23, 1996; abstract No. 167779x (for JP 08127581A, May 21, 1996.
Chemical Abstracts, vol. 93:19, Nov. 10, 1980; abstract No. 186144y (For JP 55027116A, Hokko Chemical Industry).
Chemical Abstracts, vol. 77:13, Sep. 25, 1972; abstract No. 88024j.
Rynbrandt, et al., Tetrahedron; Vol. 19, 1972, pp. 1937-1940, "The Oxidation of Aminocyclopropyl Sulfides".
Chemical Abstracts, vol. 76:21, May 22, 1972; abstract No. 126719d.
Katekar, et al., Aust. J. Chem.; vol. 25:3, 1972, pp. 647-653, "1-Thioisoflavanones and Related Compounds".
Chemical Abstracts, vol. 74:3, Jan. 18, 1971, abstract No. 13116v.
Dostert, et al., Helvetica Chimica Acta; vol. 53:7, 1970, pp. 1813-1827, "Synthese d'analogues partiellement satures des neuroleptiques tricycliques clothiapine et octoclothepine".
Chemical Abstracts, vol. 69:19; Nov. 4, 1968, abstract No. 76817s (for Janczewski, et al., Ann. Univ. Mariae Curie-Sklodowska; Vol. 21, 1967, pp. 49-64).
Chemical Abstracts; Vol. 69:19, Nov. 4, 1968, abstract No. 75267a.
Gillham, et al. Biochem. Journal; vol. 109:1, 1968, pp. 143-147, "The Isolation of Premercapturic Acids From the Urine of Animals does with Chlorobenzene and Bromobenzene".
Chemical Abstracts, vol. 67:15, Oct. 9, 1967, abstract No. 73477d.
Sen, et al., Journal Indian Chem. Soc.; vol. 43:7, 1966, pp. 521-525, "Synthesis of Potential Amoebacides. Part XXIV".
Chemical Astracts, vol. 67:9, Aug. 28, 1967; abstract No. 43615e.
Cagniant, et al., Bull. Soc. Chim. Fr., vol. 11, 1966, pp. 3674-3682, "Contributioni a l'etude des heterocycles sulfures condenses".
Chemical Abstracts, vol. 66:11, Mar. 13, 1967, abstract No. 46292n.
Degani, et al., Boll. Sci. Fac. Chim. Ind. Bologna, vol. 24:2-3, 1966, pp. 75-91, "Cationi eteroaromatici".
Chemical Abstracts, vol. 93:7, Aug. 18, 1980, abstract No. 61046m.
Johnson, et al., J. Enzyme Inhibition, vol. 2, 1987, pp. 1-22, "Collagenase Inhibitos: Their Design and Potential Therapeutic Use".
Sanquinetti, et al, CA 124 No. 8886 Method of Treating cardiac arrhythmia 1995.
Annunziata et al., CA 82 No. 170264 Acyloxyoxosulfonium intermediates, 1975.
Kindecher, CA 86 No. 94112 "Corrosion Protection of iron, 1976".
Chemical Abstract, vol. 109 No. 100759, Casadei et al., "Electrochemical Studies on Beta,-Lactams Part 3" (1988).
Chemical Abstracts vol. 123 No. 143709, Groutas et al, "The Gabriel-Colman Rearrangement in Biological Systems" (1975).
Bender Steven Lee
Broka Chris Allen
Campbell Jeffrey Allen
Castelhano Arlindo Lucas
Fisher Lawrence Emerson
Agouron Pharmaceuticals , Inc.
Covington Raymond
Kight John
Peries Rohan
Syntex (U.S.A.) Inc.
LandOfFree
Matrix metalloprotease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Matrix metalloprotease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Matrix metalloprotease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-849801